[Phot. des deux faces de la médaille à l'effigie de Louis XVI frappée en commémoration de l'expédition de la Pérouse en 1785, prise par G. Godefroy et offerte par H.B. Moinaud, avec lettre d'envoi du 16 avril 1888]

Donateur : Moinaud, H.B. (18..-18..?)

[3 phot. de gouaches : les corvettes l'Astrolabe et la Zélée prises dans la banquise, le 8 fév. 1838, par A. Coupvent-Desbois, peintre de l'expédition; prise de possession de la Terre-Adélie, par le même; tombeaux des officiers et matelots enterrés à Hobart, Tasmanie, par Mme Mary Morton Allport, le tout offert par le fils de cette dernière, Charles Allport, voir les CR. des séances de la S.G., 1891, p. 70-71]

Donateur : Allport, Charles (18..-19..)

[4 phot. des monuments élevés par Jean Joseph de La Borde dans le parc de son château de Méréville (Seine-et-Oise), à la fin du XVIIIe siècle, à la mémoire de ses deux fils, de La Borde-Marchainville et de La Borde-Boutervilliers, officiers de l'Astrolabe, péris avec La Pérouse en 1786, ainsi qu'à la mémoire du capitaine Cook, don du prince Roland Bonaparte en 1896. Voir les CR. des séances de la S.G., 1896, p. 319-321]

Donateur : Bonaparte, Roland (1858-1924)

Hepatitis G virus infection in primary Sjögren's syndrome: analysis in a series of 100 patients.

OBJECTIVE To determine the prevalence and clinical significance of hepatitis G virus (HGV) infection in a large cohort of patients with primary Sjögren¿s syndrome (SS). PATIENTS AND METHODS The study included 100 consecutive patients (92 female and eight male), with a mean age of 62 years (range 31¿80) that were prospectively visited in our unit. All patients fulfilled the European Community criteria for SS and underwent a complete history, physical examination, as well as biochemical and immunological evaluation for liver disease. Two hundred volunteer blood donors were also studied. The presence of HGV-RNA was investigated in the serum of all patients and donors. Aditionally, HBsAg and antibodies to hepatitis C virus were determined. RESULTS Four patients (4%) and six volunteer blood donors (3%) presented HGV-RNA sequences in serum. HGV infection was associated with biochemical signs of liver involvement in two (50%) patients. When compared with primary SS patients without HGV infection, no significant differences were found in terms of clinical or immunological features. HCV coinfection occurs in one (25%) of the four patients with HGV infection. CONCLUSION The prevalence of HGV infection in patients with primary SS is low in the geographical area of the study and HCV coinfection is very uncommon. HGV infection alone does not seen to be an important cause of chronic liver injury in the patients with primary SS in this area.

[9 phot. de Madagascar entre 1867 et 1900, 2 phot. par A. et G. Grandidier. Enregistré en 1970]

Comprend : Andakama sur le Mangoro, à 60 km à l'est de Tananarive. ; Femme Sakalava, vers Tulear. ; Sakalave. ; Forêt dans l'est de Madagascar. ; Sakalava from W.coast. ; VillageVangaindrano (sur le bord du Mananara) ; fort Merina (hova), côte sud-est. ; Campement du commandant Lyautey et le mien, aux environs de Fort Dauphin, en 1900. ; Madagascar : Imerina, charrue.

Muscle protein waste in tumor-bearing rats is effectively antagonized by a beta 2-adrenergic agonist (clenbuterol). Role of the ATP-ubiquitin-dependent proteolytic pathway.

Tissue protein hypercatabolism (TPH) is a most important feature in cancer cachexia, particularly with regard to the skeletal muscle. The rat ascites hepatoma Yoshida AH-130 is a very suitable model system for studying the mechanisms involved in the processes that lead to tissue depletion, since it induces in the host a rapid and progressive muscle waste mainly due to TPH (Tessitore, L., G. Bonelli, and F. M. Baccino. 1987. Biochem. J. 241:153-159). Detectable plasma levels of tumor necrosis factor-alpha associated with marked perturbations in the hormonal homeostasis have been shown to concur in forcing metabolism into a catabolic setting (Tessitore, L., P. Costelli, and F. M. Baccino. 1993. Br. J. Cancer. 67:15-23). The present study was directed to investigate if beta 2-adrenergic agonists, which are known to favor skeletal muscle hypertrophy, could effectively antagonize the enhanced muscle protein breakdown in this cancer cachexia model. One such agent, i.e., clenbuterol, indeed largely prevented skeletal muscle waste in AH-130-bearing rats by restoring protein degradative rates close to control values. This normalization of protein breakdown rates was achieved through a decrease of the hyperactivation of the ATP-ubiquitin-dependent proteolytic pathway, as previously demonstrated in our laboratory (Llovera, M., C. García-Martínez, N. Agell, M. Marzábal, F. J. López-Soriano, and J. M. Argilés. 1994. FEBS (Fed. Eur. Biochem. Soc.) Lett. 338:311-318). By contrast, the drug did not exert any measurable effect on various parenchymal organs, nor did it modify the plasma level of corticosterone and insulin, which were increased and decreased, respectively, in the tumor hosts. The present data give new insights into the mechanisms by which clenbuterol exerts its preventive effect on muscle protein waste and seem to warrant the implementation of experimental protocols involving the use of clenbuterol or alike drugs in the treatment of pathological states involving TPH, particularly in skeletal muscle and heart, such as in the present model of cancer cachexia.